EPISODE · Dec 23, 2021 · 44 MIN
Dr. Jeremy Faust, Paychex CEO & Cramer’s Outlook For Eli Lilly
from Mad Money w/ Jim Cramer · host CNBC
The Santa Claus rally continued today, with the Dow gaining 261 points, the S&P climbing 1.02%, and the NASDAQ jumping 1.18% and Jim Cramer is breaking down all the action. Next, as omicron spreads rapidly, emergency physician Dr. Jeremy Faust shares his plan that could help slow the spread. Plus, Cramer’s writing a prescription for Eli Lilly & digging into the buying opportunity the big pharma powerhouse provides. Then, what’s state of the labor market after the emergence of omicron? Cramer’s asking the head of one of the country’s biggest payroll processors, CEO of Paychex Marty Mucci. Finally, post-COVID, home is where the work is - Cramer has some stocks that could benefit from the continuing rise of the home office. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.
What this episode covers
The Santa Claus rally continued today, with the Dow gaining 261 points, the S&P climbing 1.02%, and the NASDAQ jumping 1.18% and Jim Cramer is breaking down all the action. Next, as omicron spreads rapidly, emergency physician Dr. Jeremy Faust shares his plan that could help slow the spread. Plus, Cramer’s writing a prescription for Eli Lilly & digging into the buying opportunity the big pharma powerhouse provides. Then, what’s state of the labor market after the emergence of omicron? Cramer’s asking the head of one of the country’s biggest payroll processors, CEO of Paychex Marty Mucci. Finally, post-COVID, home is where the work is - Cramer has some stocks that could benefit from the continuing rise of the home office.
NOW PLAYING
Dr. Jeremy Faust, Paychex CEO & Cramer’s Outlook For Eli Lilly
No transcript for this episode yet
Similar Episodes
Apr 29, 2025 ·12m
Apr 27, 2025 ·11m
Apr 24, 2025 ·11m
Apr 22, 2025 ·14m